Vertex Pharmaceuticals, Inc. (VRTX)
443.00
-3.83
(-0.86%)
USD |
NASDAQ |
Jun 08, 13:34
Vertex Pharmaceuticals Market Cap : 112.59B for June 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 64.35B |
| Biogen, Inc. | 28.49B |
| CRISPR Therapeutics AG | 4.991B |
| Halozyme Therapeutics, Inc. | 8.423B |
| Gilead Sciences, Inc. | 158.11B |
Market Cap Related Metrics
| PE Ratio | 26.26 |
| PS Ratio | 9.234 |
| Price to Book Value | 5.815 |
| Price to Free Cash Flow | 30.71 |
| Price | 443.00 |
| Earnings Yield | 3.81% |
| Operating PE Ratio | 23.17 |
| Normalized PE Ratio | 25.73 |